Co-expression of epidermal growth factor receptor and transforming growth factor-α predicts worse prognosis in breast-cancer patients

International Journal of Cancer

Volumn 89, Issue 6, 2000, Pages 484-487

  Umekita, Yoshihisa ^a   Ohi, Yasuyo ^a   Sagara, Yoshiatsu ^b   Yoshida, Hiroki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SAGARA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034693634     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001120)89:6<484::AID-IJC3>3.0.CO;2-S     Document Type: Article

References (24)

1. Expression of transforming growth factor α/epidermal growth factor receptor pathway in normal human breast epithelial cells
2. Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma
3. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
4. Regression modelslife-tables
5. TGF-αTGF-β in mammary carcinoma
6. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
7. The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients
8. Nonparametric estimation from incomplete observations
9. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study
10. 8th San Antonio Breast Cancer Symposium-Plenary recture. Autocrine and paracrine regulation of human breast cancer
11. Evaluation of estrogen receptor assays in human breast cancer tissue
12. Immunohistochemical demonstration of growth factors, TGF-α, TGF-β, IGF-1 and neu-oncogene product in benign and malignant human breast tissue
13. Transforming growth factor-α and endocrine sensitivity in breast cancer
14. Autocrine and paracrine growth regulation of breast cancer: Clinical implications
15. Human transforming growth factors induce tyrosine phosphorylation of EGF receptors
16. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer
17. Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer
18. Epidermal growth factor receptors and prognosis in primary breast cancer
19. Prognostic value of steroid hormone receptors: Multivariate analysis of systemically untreated patients with node negative primary breast cancer
20. Role of epidermal growth factor receptor expression in primary breast cancer: Results of a biochemical study and an immunohistochemical study
21. A prospective study of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases
22. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-α) in human breast cancer: Their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status
23. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: An immunohistochemical study
24. Estrogen receptor mutations and changes in estrogen receptor and progesterone receptor protein expression in metastatic or recurrent breast cancer